California Public Employees Retirement System Fulcrum Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$8.09 - $12.0 $242,700 - $360,000	-30,000 Closed	0 $0
Q4 2020 Feb 02, 2021	SELL	$7.84 - $13.4 $21,512 - $36,769	-2,744 Reduced 8.38%	30,000 $351,000
Q3 2020 Nov 05, 2020	BUY	$7.22 - $20.7 $7,220 - $20,700	1,000 Added 3.15%	32,744 $260,000
Q2 2020 Aug 12, 2020	BUY	$9.11 - $22.06 $289,187 - $700,272	31,744 New	31,744 $581,000

Others Institutions Holding FULC

# of Institutions

149

Shares Held

51.8M

Call Options Held

6.91M

Put Options Held

1.89M

Ra Capital Management, L.P. Boston, MA

10.2M
Shares

$37.5 Million
0.51% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

5.25M
Shares

$19.3 Million
2.43% of portfolio
Black Rock Inc. New York, NY

4.8M
Shares

$17.6 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

4.78M
Shares

$17.5 Million
1.01% of portfolio
Vanguard Group Inc Valley Forge, PA

3.27M
Shares

$12 Million
0.0% of portfolio

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $191M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account